339-43-5,MFCD00025344
Catalog No.:AA00C99I

339-43-5 | 4-Amino-N-(butylcarbamoyl)benzenesulfonamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
≥98%
in stock  
$112.00   $78.00
- +
250mg
95%
in stock  
$139.00   $97.00
- +
1g
95%
in stock  
$329.00 $230.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C99I
Chemical Name:
4-Amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number:
339-43-5
Molecular Formula:
C11H17N3O3S
Molecular Weight:
271.3360
MDL Number:
MFCD00025344
SMILES:
CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)N
Properties
Properties
 
Form:
Solid  
MP:
144-145°  
Refractive Index:
1.6630 (estimate)  
Storage:
2-8℃;Keep in dry area;  

Computed Properties
 
Complexity:
356  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1  

Literature

Title: Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.

Journal: PloS one 20120101

Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal: Journal of medicinal chemistry 20081113

Title: Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography-ion-trap tandem mass spectrometry and library searching.

Journal: Clinical chemistry 20050901

Title: History of diabetes mellitus.

Journal: Saudi medical journal 20020401

Title: Effects of sulfonylurea compounds on Pneumocystis carinii.

Journal: The Journal of infectious diseases 19860501

Title: Liver damage and estrogen therapy of prostatic cancer. Case report.

Journal: Scandinavian journal of urology and nephrology 19720101

Title: [Cytopenias caused by hypoglycemic sulfonamides].

Journal: Journees annuelles de diabetologie de l'Hotel-Dieu 19680101

Title: Kleinsorge H, et al. Carbutamide--the first oral antidiabetic. A retrospect. Exp Clin Endocrinol Diabetes. 1998;106(2):149-51.

Title: ROOT MA, et al. Pharmacology of carbutamide (p-aminophenylsulfonyl butylcarbamide). J Pharmacol Exp Ther. 1957 Apr;119(4):468-78.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:339-43-5 Molecular Formula|339-43-5 MDL|339-43-5 SMILES|339-43-5 4-Amino-N-(butylcarbamoyl)benzenesulfonamide
Catalog No.: AA00C99I
339-43-5,MFCD00025344
339-43-5 | 4-Amino-N-(butylcarbamoyl)benzenesulfonamide
Pack Size: 50mg
Purity: ≥98%
in stock
$112.00 $78.00
Pack Size: 250mg
Purity: 95%
in stock
$139.00 $97.00
Pack Size: 1g
Purity: 95%
in stock
$329.00 $230.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C99I
Chemical Name: 4-Amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number: 339-43-5
Molecular Formula: C11H17N3O3S
Molecular Weight: 271.3360
MDL Number: MFCD00025344
SMILES: CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)N
Properties
Form: Solid  
MP: 144-145°  
Refractive Index: 1.6630 (estimate)  
Storage: 2-8℃;Keep in dry area;  
Complexity: 356  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1  
Literature fold

Title: Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.

Journal: PloS one20120101

Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal: Journal of medicinal chemistry20081113

Title: Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography-ion-trap tandem mass spectrometry and library searching.

Journal: Clinical chemistry20050901

Title: History of diabetes mellitus.

Journal: Saudi medical journal20020401

Title: Effects of sulfonylurea compounds on Pneumocystis carinii.

Journal: The Journal of infectious diseases19860501

Title: Liver damage and estrogen therapy of prostatic cancer. Case report.

Journal: Scandinavian journal of urology and nephrology19720101

Title: [Cytopenias caused by hypoglycemic sulfonamides].

Journal: Journees annuelles de diabetologie de l'Hotel-Dieu19680101

Title: Kleinsorge H, et al. Carbutamide--the first oral antidiabetic. A retrospect. Exp Clin Endocrinol Diabetes. 1998;106(2):149-51.

Title: ROOT MA, et al. Pharmacology of carbutamide (p-aminophenylsulfonyl butylcarbamide). J Pharmacol Exp Ther. 1957 Apr;119(4):468-78.

Building Blocks More >
38862-29-2
38862-29-2
2-Amino-4-hydroxy-6-chloro-s-triazine
AA00C9G9 | MFCD16251190
37987-26-1
37987-26-1
4-Hydroxy-3,5-diiodobenzyl Alcohol
AA00C9NU | MFCD06203112
34621-73-3
34621-73-3
2-O-(2-ACETAMIDO-2-DOEXY-B-D-GLUCOPYRANO SYL)-D-MAN
AA00C9T8 | MFCD01311886
320-84-3
320-84-3
5-Chloro-2-(trifluoromethyl)benzoyl chloride
AA00CA03 | MFCD01631354
3273-78-7
3273-78-7
4,4'-DIAMINO-3,3'-DINITRODIPHENYL ETHER
AA00CABL | MFCD00050456
4163-79-5
4163-79-5
2,6-DIMETHYLTHIOANISOLE
AA00CAS6 | MFCD03789165
21279-58-3
21279-58-3
1-(Pyrimidin-2-yl)-1,4-diazepane dihydrochloride
AA00CBCN | MFCD15071933
26454-79-5
26454-79-5
2-(2-Oxo-2-(4-methoxyphenyl)ethyl)malononitrile
AA00CDRR | MFCD09835069
218594-74-2
218594-74-2
(R)-3-(Methoxymethyl)morpholine hydrochloride
AA00CFZC | MFCD09608106
3696-37-5
3696-37-5
Ethylmalononitrile
AA00CH6C | MFCD01715998
Submit
© 2017 AA BLOCKS, INC. All rights reserved.